Sign inJoin waitlistJoin the waitlist

Patrick Hwu

President and CEO · University of South Florida Morsani College of Medicine

Credentials: · · · · ·

History

H. Lee Moffitt Cancer Center and Research Institute
2021–Present

Medical Oncology
1990–1992
Internal Medicine
1987–1990
University of Texas MD Anderson Cancer Center
MED COLL OF PENNSYLVANIA, PHILADELPHIA
1983–1987

Research

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
New England Journal of Medicine · 2012 · 6,533 citations
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Science · 2018 · 3,866 citations
B cells and tertiary lymphoid structures promote immunotherapy response
Nature · 2020 · 2,219 citations

Michael Davies
66 papers
WH
Wen-Jen Hwu
45 papers
KK
Kevin Kim
44 papers
Sapna Patel
43 papers
AD
Adi Diab
40 papers
Alexander Lazar
40 papers · 16 as a fellow
Jennifer Wargo
40 papers
Steven Rosenberg
40 papers
Rodabe Amaria
36 papers
AB
Agop Bedikian
35 papers
Jeffrey Gershenwald
34 papers
Scott Woodman
34 papers · 2 as a fellow

Grants

Identification and Assessment of Unconventional Tumor-Associated Antigens as Potential Targets for Cytotoxic T-Cell Based Immunotherapy of Cancer
National Cancer Institute · R01
PI · $2.9M · University of Tx Md Anderson Can Ctr
2022–2027
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
National Cancer Institute · P50
Contact PI · $2.3M · University of Tx Md Anderson Can Ctr
2019–2024
Biomarkers and Resistance Mechanisms in Melanoma T-Cell Therapy
National Cancer Institute · R01
Contact PI · $1.7M · University of Tx Md Anderson Can Ctr
2014–2020
The Role of the PI3K Pathway in Immune Resistance
National Cancer Institute · R01
Contact PI · $2M · University of Tx Md Anderson Can Ctr
2014–2020

Clinical trials

Melanoma Vaccine With Peptides and Leuprolide
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2005–2012